UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 38

Sortiert nach

PRM65 Prevalence-Based Versus Incidence-Based Economic Evaluations for the Assessment of New Health Care Interventions

Value in health, 2012-06, Vol.15 (4), p.A170-A170

Mauskopf, J.A

2012

Volltextzugriff (PDF)

Systematic Literature Review to Identify Cost Estimates of Liver Disease in Those with Chronic Hepatitis C Virus (Hcv) In The United States

Value in health, 2015-05, Vol.18 (3), p.A236-A236

2015

Volltextzugriff (PDF)

Review of cost-effectiveness analyses of varicella vaccination: which model structure assumptions and input parameters matter?

Value in health, 2015-05, Vol.18 (3), p.A14-A15

2015

Volltextzugriff (PDF)

Cost–utility Analysis of Lisdexamfetamine Dimesylate in the Treatment of Adults with Attention-deficit/hyperactivity Disorder in the United Kingdom

European psychiatry, 2015-03, Vol.30, p.1607-1607

2015

Volltextzugriff (PDF)

Estimating Costs in A Cost-Effectiveness Analysis: Adherence to HTA Guidance

Value in health, 2014-11, Vol.17 (7), p.A548-A548

2014

Volltextzugriff (PDF)

Budget Impact Of Adding Delayed-Release Dimethyl Fumarate To The Formulary For The Treatment Of Relapsing Forms Of Multiple Sclerosis

Value in health, 2014-05, Vol.17 (3), p.A58-A58

2014

Volltextzugriff (PDF)

Cost-Effectiveness Of Delayed-Release Dimethyl Fumarate Compared To Glatiramer Acetate And Fingolimod For The Treatment Of Relapsing-Remitting Multiple Sclerosis

Value in health, 2014-05, Vol.17 (3), p.A60-A61

2014

Volltextzugriff (PDF)

Developing Realistic Pathways in Cost-Effectiveness Models for Psoriasis: What to Do When a Biologic Fails

Value in health, 2013-11, Vol.16 (7), p.A588-A588

2013

Volltextzugriff (PDF)

Comparing vaccine effectiveness estimates in cost-effectiveness analyses of pneumococcal vaccination in adults

Value in health, 2013-05, Vol.16 (3), p.A17-A17

2013

Volltextzugriff (PDF)

Patient-level simulation modeling for economic evaluations: Opportunities and challenges in a practical setting

Value in health, 2013-05, Vol.16 (3), p.A28-A29

2013

Volltextzugriff (PDF)

PHP118 Estimating the Probability of a Recommendation for Reimbursement for a New Drug in the UK Using an MCDA Approach

Value in health, 2012-11, Vol.15 (7), p.A309-A310

2012

Volltextzugriff (PDF)

Cost-Utility Analysis of Lisdexamfetamine in the Treatment of Children and Adolescents with Attention-Deficit/Hyperactivity Disorder in the United Kingdom

Value in health, 2013-11, Vol.16 (7), p.A549-A549

2013

Volltextzugriff (PDF)

Methodological Challenges of Cost-Of-Illness Studies on Dementia: An International Systematic Review

Value in health, 2013-11, Vol.16 (7), p.A545-A545

2013

Volltextzugriff (PDF)

Relationship Between Modelling Approach and Reported Outcomes: Case Studies of Models for the Treatment of Schizophrenia

Value in health, 2013-11, Vol.16 (7), p.A589-A589

2013

Volltextzugriff (PDF)

IN3 Translating Outcomes from a Dynamic Transmission Model for Varicella Vaccination to Cost-Effectiveness Estimates: The Impact of Different Analytic Approaches on the Results

Value in health, 2012-06, Vol.15 (4), p.A10-A10

2012

Volltextzugriff (PDF)

PIN47 The Humanistic and Economic Burden of Hepatitis C Across the United States, Europe, and Asia

Value in health, 2012-06, Vol.15 (4), p.A245-A246

2012

Volltextzugriff (PDF)

Surgical Innovation: Do We Need A More Balanced Framework For Evidence?

Value in health, 2013-05, Vol.16 (3), p.A247-A247

2013

Volltextzugriff (PDF)

NI4 The Association between Financial Impact and the likelihood of recommendation of Medicines for Use in England and Wales

Value in health, 2011, Vol.14 (7), p.A238-A238

2011

Volltextzugriff (PDF)

PRM27 - Review of cost-effectiveness analyses of varicella vaccination: which model structure assumptions and input parameters matter?

Value in health, 2015-05, Vol.18 (3), p.A14-A15

2015

Volltextzugriff (PDF)

PRM30 - Estimating Costs in A Cost-Effectiveness Analysis: Adherence to HTA Guidance

Value in health, 2014-11, Vol.17 (7), p.A548-A548

2014

Volltextzugriff (PDF)

Rate, Type and Cost of Invasive Interventions for Uterine Fibroids in Germany, France, and England

Journal of minimally invasive gynecology, 2008, Vol.15 (6), p.13S-13S

2008

Volltextzugriff (PDF)

PIN50 - Systematic Literature Review to Identify Cost Estimates of Liver Disease in Those with Chronic Hepatitis C Virus (Hcv) In The United States

Value in health, 2015-05, Vol.18 (3), p.A236-A236

2015

Volltextzugriff (PDF)

PRM24 - Comparing vaccine effectiveness estimates in cost-effectiveness analyses of pneumococcal vaccination in adults

Value in health, 2013-05, Vol.16 (3), p.A17-A17

2013

Volltextzugriff (PDF)

PRM89 - Patient-level simulation modeling for economic evaluations: Opportunities and challenges in a practical setting

Value in health, 2013-05, Vol.16 (3), p.A28-A29

2013

Volltextzugriff (PDF)

PND25 - Cost-Effectiveness Of Delayed-Release Dimethyl Fumarate Compared To Glatiramer Acetate And Fingolimod For The Treatment Of Relapsing-Remitting Multiple Sclerosis

Value in health, 2014-05, Vol.17 (3), p.A60-A61

2014

Volltextzugriff (PDF)

1 – 25 von 38

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(38)
Mit Volltextzugriff
(36)

Publikationsform

Artikel
(37)
Tagungsberichte
(1)

Sprache

Englisch
(38)
Japanisch
(2)

Erscheinungsjahr

n.n

Thema

Internal Medicine
(18)
Science & Technology
(7)
Physical Sciences
(6)
Astronomy & Astrophysics
(3)
Detectors
(3)
Inductance
(3)
Arrays
(2)
Astronomy
(2)
Galaxies
(2)
Humans
(2)
Instrumentation: Detectors
(2)
Life Sciences & Biomedicine
(2)
Physics
(2)
Physics, Applied
(2)
Public, Environmental & Occupational Health
(2)
Regulation
(2)
Sensors
(2)
Submillimeter: General
(2)
290300 - Energy Planning & Policy- Environment, Health, & Safety
(1)
560300 - Chemicals Metabolism & Toxicology
(1)

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

PRM65 Prevalence-Based Versus Incidence-Based Economic Evaluations for the Assessment of New Health Care Interventions

Systematic Literature Review to Identify Cost Estimates of Liver Disease in Those with Chronic Hepatitis C Virus (Hcv) In The United States

Review of cost-effectiveness analyses of varicella vaccination: which model structure assumptions and input parameters matter?

Cost–utility Analysis of Lisdexamfetamine Dimesylate in the Treatment of Adults with Attention-deficit/hyperactivity Disorder in the United Kingdom

Estimating Costs in A Cost-Effectiveness Analysis: Adherence to HTA Guidance

Budget Impact Of Adding Delayed-Release Dimethyl Fumarate To The Formulary For The Treatment Of Relapsing Forms Of Multiple Sclerosis

Cost-Effectiveness Of Delayed-Release Dimethyl Fumarate Compared To Glatiramer Acetate And Fingolimod For The Treatment Of Relapsing-Remitting Multiple Sclerosis

Developing Realistic Pathways in Cost-Effectiveness Models for Psoriasis: What to Do When a Biologic Fails

Comparing vaccine effectiveness estimates in cost-effectiveness analyses of pneumococcal vaccination in adults

Patient-level simulation modeling for economic evaluations: Opportunities and challenges in a practical setting

PHP118 Estimating the Probability of a Recommendation for Reimbursement for a New Drug in the UK Using an MCDA Approach

Cost-Utility Analysis of Lisdexamfetamine in the Treatment of Children and Adolescents with Attention-Deficit/Hyperactivity Disorder in the United Kingdom

Methodological Challenges of Cost-Of-Illness Studies on Dementia: An International Systematic Review

Relationship Between Modelling Approach and Reported Outcomes: Case Studies of Models for the Treatment of Schizophrenia

IN3 Translating Outcomes from a Dynamic Transmission Model for Varicella Vaccination to Cost-Effectiveness Estimates: The Impact of Different Analytic Approaches on the Results

PIN47 The Humanistic and Economic Burden of Hepatitis C Across the United States, Europe, and Asia

Surgical Innovation: Do We Need A More Balanced Framework For Evidence?

NI4 The Association between Financial Impact and the likelihood of recommendation of Medicines for Use in England and Wales

PRM27 - Review of cost-effectiveness analyses of varicella vaccination: which model structure assumptions and input parameters matter?

PRM30 - Estimating Costs in A Cost-Effectiveness Analysis: Adherence to HTA Guidance

Rate, Type and Cost of Invasive Interventions for Uterine Fibroids in Germany, France, and England

PIN50 - Systematic Literature Review to Identify Cost Estimates of Liver Disease in Those with Chronic Hepatitis C Virus (Hcv) In The United States

PRM24 - Comparing vaccine effectiveness estimates in cost-effectiveness analyses of pneumococcal vaccination in adults

PRM89 - Patient-level simulation modeling for economic evaluations: Opportunities and challenges in a practical setting

PND25 - Cost-Effectiveness Of Delayed-Release Dimethyl Fumarate Compared To Glatiramer Acetate And Fingolimod For The Treatment Of Relapsing-Remitting Multiple Sclerosis

Suchergebnisse filtern